Memo Therapeutics reveals positive AntiBKV data
Therapy involves renal transplant patients requiring treatment of BK polyomavirus infection
Read More
Tag: MEMO
Memo Therapeutics initiates pioneering BK virus therapy trial
Antibody addresses high unmet medical need in rapidly growing kidney transplant market
Read More
New consortium will monitor safety/efficacy of COVID-19 vaccines
The move provides the opportunity to conduct essential post-marketing surveillance
Read More
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
- FDA approves once‑weekly Sogroya for wider paediatric use
- SolasCure trial shows faster healing with Aurase Wound Gel
